Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Bantel

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Journal of Hepatology|June 25, 2017
miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene NfibSanchari Roy, Heike Bantel, Franziska Wandrer, et al.
Oncotarget|February 9, 2017
The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinomaAndreas Geier, Rocio I R Macias, Dominik Bettinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinomaChristian Breunig, Bernadett J Mueller, Ludmila Umansky, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patientsMartin Franck, Katharina John, Sherin Al Aoua, et al.
Hepatology (Baltimore, Md.)|April 9, 2008
Caspase activation is associated with spontaneous recovery from acute liver failureXandra Volkmann, Matthias Anstaett, Johannes Hadem, et al.
Nature Communications|June 24, 2016
MicroRNA-125b-5p mimic inhibits acute liver failureDakai Yang, Qinggong Yuan, Asha Balakrishnan, et al.
Hepatology (Baltimore, Md.)|October 14, 2011
Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitisDiana Joka, Kristin Wahl, Sarah Moeller, et al.
Hepatology (Baltimore, Md.)|June 11, 2014
MicroRNAs play a role in spontaneous recovery from acute liver failureKatharina John, Johannes Hadem, Till Krech, et al.
Hepatology Communications|November 14, 2025
Optimizing clinic consultations in primary biliary cholangitis: International consensus recommendationsHeike Bantel, Gideon M Hirschfield, David E Jones, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|June 25, 2017
miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene NfibSanchari Roy, Heike Bantel, Franziska Wandrer, et al.
Oncotarget|February 9, 2017
The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinomaAndreas Geier, Rocio I R Macias, Dominik Bettinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinomaChristian Breunig, Bernadett J Mueller, Ludmila Umansky, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patientsMartin Franck, Katharina John, Sherin Al Aoua, et al.
Hepatology (Baltimore, Md.)|April 9, 2008
Caspase activation is associated with spontaneous recovery from acute liver failureXandra Volkmann, Matthias Anstaett, Johannes Hadem, et al.
Nature Communications|June 24, 2016
MicroRNA-125b-5p mimic inhibits acute liver failureDakai Yang, Qinggong Yuan, Asha Balakrishnan, et al.
Hepatology (Baltimore, Md.)|October 14, 2011
Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitisDiana Joka, Kristin Wahl, Sarah Moeller, et al.
Hepatology (Baltimore, Md.)|June 11, 2014
MicroRNAs play a role in spontaneous recovery from acute liver failureKatharina John, Johannes Hadem, Till Krech, et al.
Hepatology Communications|November 14, 2025
Optimizing clinic consultations in primary biliary cholangitis: International consensus recommendationsHeike Bantel, Gideon M Hirschfield, David E Jones, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Pageof 11